Marios Arvanitis
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
98
Citations
3,470
Est. group size
—
Recurring co-author estimate
Active years
31
Publishing since 1996
Marios Arvanitis studies the genetics of cardiovascular and blood-related diseases, using large population datasets and computational methods to link genetic variation to conditions like atherosclerosis, obesity, clotting factor levels, and clonal blood cell disorders. His work combines statistical genetics (genome-wide association studies, or GWAS), functional genomics, and lab experiments to identify genes and biological mechanisms underlying these conditions. This research aims to help predict disease risk and understand the biological pathways connecting genes to cardiovascular and hematologic outcomes.
Publication output has grown over the last decade, increasing from a handful of papers per year in 2017-2018 to a sustained pace of about 9-13 publications annually from 2022 onward.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Epidemiology and Natural History of Preclinical and Clinical Obesity: Insights From a <scp>UK</scp> Cohort
Obesity · 2026
- RAB5C Increases Endothelial Release of VWF by Regulating Vesicle Trafficking
Arteriosclerosis Thrombosis and Vascular Biology · 2026
- Genome-wide analysis and polygenic prediction of clinical obesity and comparison with body mass index
medRxiv · 2026
- Functional Genomics Link REST to Endothelial Plasticity and Atherosclerosis
Circulation Research · 2025
- C-C motif chemokine receptor-like 2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>
Haematologica · 2025
- Prioritization of causal genes from genome-wide association studies by Bayesian data integration across loci
PLoS Computational Biology · 2025
- CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Sparse matrix factorization robust to sample sharing across GWASs reveals interpretable genetic components
The American Journal of Human Genetics · 2025
- Epidemiology and Natural History of Preclinical and Clinical Obesity: Insights from the UK Biobank
SSRN Electronic Journal · 2025
- A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels
UNC Libraries · 2025
- Genome-wide characterization of clonal hematopoiesis reveals extensive non-coding putative driver mutations
medRxiv · 2025
- Differential Performance of Polygenic Score for Coronary Artery Disease Based on Coronary Artery Calcium Between Men Living With and Without HIV
Journal of the American Heart Association · 2025
- Prior knowledge informs graph neural networks to improve phenotype prediction from proteomics
medRxiv · 2025
- HMGA1 chromatin regulator induces inflammatory signals and promotes atherogenesis in Tet2 mutant clonal hematopoiesis
Blood · 2025
- A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels
Blood · 2024
- medRxiv×8
- Circulation×7
- bioRxiv (Cold Spring Harbor Laboratory)×6
- UNC Libraries×5
- Nature Communications×4
- Taeho Jo
Biochemistry, Genetics and Molecular Biology · Indiana University
- Juan Shu
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Bingxin Zhao
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Jason H. Moore
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Zirui Fan
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile